The DOI matches its Crossref record; 118 of the 122 references it cites were found in a registry or an index.
Glucagon-Like Peptide 1 Interacts with Ghrelin and Leptin to Regulate Glucose Metabolism and Food Intake through Vagal Afferent Neuron Signaling ,
Open accessAbstract
Emerging evidence has suggested a possible physiologic role for peripheral glucagon-like peptide 1 (GLP-1) in regulating glucose metabolism and food intake. The likely site of action of GLP-1 is on vagal afferent neurons (VANs). The vagal afferent pathway is the major neural pathway by which information about ingested nutrients reaches the central nervous system and influences feeding behavior. Peripheral GLP-1 acts on VANs to inhibit food intake. The mechanism of the GLP-1 receptor (GLP-1R) is unlike other gut-derived receptors; GLP-1Rs change their cellular localization according to feeding status rather than their protein concentrations. It is possible that several gut peptides are involved in mediating GLP-1R translocation. The mechanism of peripheral GLP-1R translocation still needs to be elucidated. We review data supporting the role of peripheral GLP-1 acting on VANs in influencing glucose homeostasis and feeding behavior. We highlight evidence demonstrating that GLP-1 interacts with ghrelin and leptin to induce satiation. Our aim was to understand the mechanism of peripheral GLP-1 in the development of noninvasive antiobesity treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GLP‐1 and GIP work synergistically to potentiate glucose‐stimulated insulin secretion by pancreatic β‐cells 21.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [21]
In the citing paper
“A major target for gut‐derived hormones is the vagal afferent neurons (VANs) 21.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [21]
In the citing paper
“Ghrelin attenuates insulin production and increases blood glucose concentration by promoting the intracellular localization of the pancreatic β‐cell GLP‐1R under fasting conditions, thus counteracting GLP‐1 signaling 21.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
Watterson, K. R., Bestow, D., Gallagher, J. R., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2012) · Neurosignals · doi:10.1159/000334144 · Cited by 3,395
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Srimaroeng, C., Cecile, J. P., Walden, R., & Pritchard, J. B. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350077 · Cited by 2,989
Ghrelin enhances appetite and increases food intake in humans
Wren, A. M., Seal, L. J., Cohen, M. A., Brynes, A. E., Frost, G. S., Murphy, K. G., Dhillo, W. S., Ghatei, M. A., & Bloom, S. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8111 · Cited by 2,494
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Identification of targets of leptin action in rat hypothalamus.
Schwartz, M. W., Seeley, R. J., Campfield, L. A., Burn, P., & Baskin, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118891 · Cited by 1,499
The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review
Klok, M. D., Jakobsdottir, S., & Drent, M. L. (2007) · Obesity Reviews · doi:10.1111/j.1467-789x.2006.00270.x · Cited by 1,442
Zander, M., Madsbad, S., Madsen, J. L., & Holst, J. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07952-7 · Cited by 1,297
The stomach is a source of leptin
Bado, A., Levasseur, S., Attoub, S., Kermorgant, S., Laigneau, J., Bortoluzzi, M.-N., Moizo, L., Lehy, T., Guerre-Millo, M., MARCHAND‐BRUSTEL, Y. L., et al. (1998) · Nature · doi:10.1038/29547 · Cited by 1,242
Kieffer, T. J., McIntosh, C. H., & Pederson, R. A. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628397 · Cited by 1,124
Date, Y., Murakami, N., Toshinai, K., Matsukura, S., Niijima, A., Matsuo, H., Kangawa, K., & Nakazato, M. (2002) · Gastroenterology · doi:10.1053/gast.2002.35954 · Cited by 1,099
Nauck, M. A., Kleine, N., �rskov, C., Holst, J. J., Willms, B., & Creutzfeldt, W. (1993) · Diabetologia · doi:10.1007/bf00401145 · Cited by 1,092
Winzell, M. S., & Åhrén, B. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s215 · Cited by 1,028
Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis
Balthasar, N., Coppari, R., McMinn, J., Liu, S. M., Lee, C. E., Tang, V., Kenny, C. D., McGovern, R. A., Chua, S. C., Elmquist, J. K., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.004 · Cited by 935
Thorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906
Mojsov, S., Weir, G. C., & Habener, J. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112855 · Cited by 889
NAUCK, M. A., HOMBERGER, E., SIEGEL, E. G., ALLEN, R. C., EATON, R. P., EBERT, R., & CREUTZFELDT, W. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-2-492 · Cited by 874
on behalf of the NN8022-1923 Investigators, Wadden, T. A., Hollander, P., Klein, S., Niswender, K., Woo, V, Hale, P. M., & Aronne, L. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.120 · Cited by 842
Scrocchi, L. A., Brown, T. J., Maclusky, N., Brubaker, P. L., Auerbach, A. B., Joyner, A. L., & Drucker, D. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1254 · Cited by 793
Deacon, C. F., Johnsen, A. H., & Holst, J. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7883856 · Cited by 792
Mechanisms of action of glucagon-like peptide 1 in the pancreas
Doyle, M. E., & Egan, J. M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.11.007 · Cited by 702
Elliott, R. M., Morgan, L. M., Tredger, J. A., Deacon, S., Wright, J., & Marks, V. (1993) · Journal of Endocrinology · doi:10.1677/joe.0.1380159 · Cited by 695
Shutter, J. R., Graham, M., Kinsey, A. C., Scully, S. A., Lüthy, R., & Stark, K. L. (1997) · Genes & Development · doi:10.1101/gad.11.5.593 · Cited by 672
Kamegai, J., Tamura, H., Shimizu, T., Ishii, S., Sugihara, H., & Wakabayashi, I. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2438 · Cited by 624
Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor
Bullock, B. P., Heller, R. S., & Habener, J. F. (1996) · Endocrinology · doi:10.1210/endo.137.7.8770921 · Cited by 622
Abbott, C. R., Monteiro, M. P., Small, C. J., Sajedi, A., Smith, K. L., Parkinson, J. R. C., Ghatei, M. A., & Bloom, S. R. (2005) · Brain Research · doi:10.1016/j.brainres.2005.03.011 · Cited by 617
Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats
Tang-Christensen, M., Larsen, P. J., Goke, R., Fink-Jensen, A., Jessop, D. S., Moller, M., & Sheikh, S. P. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.4.r848 · Cited by 597
Hansen, L., Deacon, C. F., Ørskov, C., & Holst, J. J. (1999) · Endocrinology · doi:10.1210/endo.140.11.7143 · Cited by 595
The Influence of GLP-1 on Glucose-Stimulated Insulin Secretion
Kjems, L. L., Holst, J. J., Vølund, A., & Madsbad, S. (2003) · Diabetes · doi:10.2337/diabetes.52.2.380 · Cited by 582
Glucagon-like peptide-1: a potent regulator of food intake in humans
Gutzwiller, J.-P., Göke, B., Drewe, J., Hildebrand, P., Ketterer, S., Handschin, D., Winterhalder, R., Conen, D., & Beglinger, C. (1999) · Gut · doi:10.1136/gut.44.1.81 · Cited by 577
Thorens, B., Porret, A., Bühler, L. H., Deng, S., Morel, P., & Widmann, C. (1993) · Diabetes · doi:10.2337/diab.42.11.1678 · Cited by 555
Kolterman, O., Buse, J. B., Fineman, M. S., Gaines, E., Heintz, S., Bicsak, T. A., Taylor, K., Kim, D. S., Aisporna, M., Wang, Y., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021545 · Cited by 549
Ghrelin-Induced Food Intake Is Mediated via the Orexin Pathway
Toshinai, K., Date, Y., Murakami, N., Shimada, M., Mondal, M. S., Shimbara, T., Guan, J., Wang, Q., Funahashi, H., Sakurai, T., et al. (2003) · Endocrinology · doi:10.1210/en.2002-220788 · Cited by 470
Miyawaki, K., Yamada, Y., Yano, H., Niwa, H., Ban, N., Ihara, Y., Kubota, A., Fujimoto, S., Kajikawa, M., Kuroe, A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14843 · Cited by 454
Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice
Thornton, J. E., Cheung, C. C., Clifton, D. K., & Steiner, R. A. (1997) · Endocrinology · doi:10.1210/endo.138.11.5651 · Cited by 437 · cited 1×
“For example, ob/ob mice have increased degrees of orexigenic AgRP expression and decreased anorexigenic POMC expression (104, 105).”
Holz, G. G. (2004) · Diabetes · doi:10.2337/diabetes.53.1.5 · Cited by 392
Peptide YY3–36 and Glucagon-Like Peptide-17–36 Inhibit Food Intake Additively
Neary, N. M., Small, C. J., Druce, M. R., Park, A. J., Ellis, S. M., Semjonous, N. M., Dakin, C. L., Filipsson, K., Wang, F., Kent, A. S., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0237 · Cited by 371
GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine
Mortensen, K., Lundby‐Christensen, L., Holst, J. J., & Ørskov, C. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(03)00125-3 · Cited by 364
Parker, H. E., Habib, A. M., Rogers, G. J., Gribble, F. M., & Reimann, F. (2009) · Diabetologia · doi:10.1007/s00125-008-1202-x · Cited by 324
Arcuate Glucagon-Like Peptide 1 Receptors Regulate Glucose Homeostasis but Not Food Intake
Sandoval, D. A., Bagnol, D., Woods, S. C., D’Alessio, D. A., & Seeley, R. J. (2008) · Diabetes · doi:10.2337/db07-1824 · Cited by 324
Vahl, T. P., Tauchi, M., Durler, T. S., Elfers, E. E., Fernandes, T. M., Bitner, R. D., Ellis, K. S., Woods, S. C., Seeley, R. J., Herman, J. P., et al. (2007) · Endocrinology · doi:10.1210/en.2006-0153 · Cited by 318 · cited 1×
“Of interest, GLP-1Rs have been localized in the portal vein, and a blockade of these GLP-1Rs substantially impairs glucose tolerance in rodents (43).”
Meeran, K., O’Shea, D., Edwards, C. M. B., Turton, M. D., Heath, M. M., Gunn, I., Abusnana, S., Rossi, M., Small, C. J., Goldstone, A. P., et al. (1999) · Endocrinology · doi:10.1210/endo.140.1.6421 · Cited by 303
Evidence that Intestinal Glucagon-Like Peptide-1 Plays a Physiological Role in Satiety
Williams, D. L., Baskin, D. G., & Schwartz, M. W. (2009) · Endocrinology · doi:10.1210/en.2008-1045 · Cited by 300
Ørskov, C., Poulsen, S. S., Mørten, M., & Holst, J. J. (1996) · Diabetes · doi:10.2337/diab.45.6.832 · Cited by 300
Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig
Deacon, C. F., Pridal, L., Klarskov, L., Olesen, M., & Holst, J. J. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.3.e458 · Cited by 299
Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors
Holst, J. J., & Deacon, C. F. (2005) · Diabetologia · doi:10.1007/s00125-005-1705-7 · Cited by 287
Role of Leptin in the Regulation of Glucagon-Like Peptide-1 Secretion
Anini, Y., & Brubaker, P. L. (2003) · Diabetes · doi:10.2337/diabetes.52.2.252 · Cited by 287
Kanoski, S. E., Rupprecht, L. E., Fortin, S. M., De Jonghe, B. C., & Hayes, M. R. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.022 · Cited by 273
Rüttimann, E. B., Arnold, M., Hillebrand, J. J., Geary, N., & Langhans, W. (2008) · Endocrinology · doi:10.1210/en.2008-1221 · Cited by 259
The role of leptin receptor signaling in feeding and neuroendocrine function
Bates, S. H., & Myers, M. G. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2003.10.003 · Cited by 245
Gedulin, B. R., Nikoulina, S. E., Smith, P. A., Gedulin, G., Nielsen, L. L., Baron, A., Parkes, D. G., & Young, A. A. (2004) · Endocrinology · doi:10.1210/en.2004-1349 · Cited by 241
Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin
Moran, T. H., Baldessarini, A. R., Salorio, C. F., Lowery, T. R., & Schwartz, G. J. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.272.4.r1245 · Cited by 236
Hayes, M. R., Leichner, T. M., Zhao, S., Lee, G., Chowansky, A., Zimmer, D. J., Jonghe, B. C. D., Kanoski, S. E., Grill, H. J., & Bence, K. K. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.001 · Cited by 234
Structure and Physiological Actions of Ghrelin
Delporte, C. (2013) · Scientifica · doi:10.1155/2013/518909 · Cited by 232
Hayes, M. R., Bradley, L. E., & Grill, H. J. (2009) · Endocrinology · doi:10.1210/en.2008-1479 · Cited by 228
Glucagon-Like Peptide 1 Secretion by the L-Cell
Lim, G. E., & Brubaker, P. L. (2006) · Diabetes · doi:10.2337/db06-s020 · Cited by 220
Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms
Balkan, B., & Li, X. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.4.r1449 · Cited by 201
Scott, M. M., Williams, K. W., Rossi, J., Lee, C. E., & Elmquist, J. K. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43703 · Cited by 190
GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice
Hansotia, T., & Drucker, D. J. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.07.019 · Cited by 187
Burdyga, G., Varró, A., Dimaline, R., Thompson, D. G., & Dockray, G. J. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00543.2005 · Cited by 187
Capsaicin pretreatment attenuates suppression of food intake by cholecystokinin
Ritter, R. C., & Ladenheim, E. E. (1985) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1985.248.4.r501 · Cited by 186
Habib, A. M., Richards, P., Rogers, G. J., Reimann, F. M., & Gribble, F. M. (2013) · Diabetologia · doi:10.1007/s00125-013-2887-z · Cited by 184
Appetite signaling: From gut peptides and enteric nerves to brain
Näslund, E. B., & Hellström, P. M. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.05.017 · Cited by 181
Lamont, B. J., Li, Y., Kwan, E. P., Brown, T. J., Gaisano, H. Y., & Drucker, D. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42497 · Cited by 180
Diet-induced obesity leads to the development of leptin resistance in vagal afferent neurons
de Lartigue, G., Barbier de la Serre, C., Espero, E., Lee, J., & Raybould, H. E. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00056.2011 · Cited by 179
Self-citationLeptin Regulation of the Anorexic Response to Glucagon-Like Peptide-1 Receptor Stimulation
Williams, D. L., Baskin, D. G., & Schwartz, M. W. (2006) · Diabetes · doi:10.2337/db06-0558 · Cited by 179
Dunphy, J. L., Taylor, R. G., & Fuller, P. J. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00096-3 · Cited by 165
Smith, E. P., An, Z., Wagner, C., Lewis, A. G., Cohen, E. B., Li, B., Mahbod, P., Sandoval, D. A., Pérez–Tilve, D., Tamarina, N. A., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.04.005 · Cited by 165
de Fonseca, F. R., Navarro, M. A., Álvarez, E., Roncero, I., Chowen, J. A., Maestre, O., de Heras, R. G., Muñoz, R. M., Eng, J., & Blázquez, E. (2000) · Metabolism · doi:10.1053/meta.2000.6251 · Cited by 157
Tang‐Christensen, M., Havel, P. J., Jacobs, R. R., Larsen, P. J., & Cameron, J. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5458 · Cited by 156
Caveolin-1 Regulates Cellular Trafficking and Function of the Glucagon-Like Peptide 1 Receptor
Syme, C. A., Zhang, L., & Bisello, A. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0178 · Cited by 141
Insulin-like peptide 5 is an orexigenic gastrointestinal hormone
Grosse, J., Heffron, H., Burling, K., Hossain, M. A., Habib, A. M., Rogers, G. J., Richards, P., Larder, R., Rimmington, D., Adriaenssens, A. E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411413111 · Cited by 139
Receptor‐mediated activation of gastric vagal afferents by glucagon‐like peptide‐1 in the rat
Bucinskaite, V., Tolessa, T., Pedersen, J., Rydqvist, B., Zerihun, L., Holst, J. J., & Hellström, P. M. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01317.x · Cited by 139
de Lartigue, G., Dimaline, R., Varró, A., & Dockray, G. J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5508-06.2007 · Cited by 127
Deletion of leptin signaling in vagal afferent neurons results in hyperphagia and obesity
de Lartigue, G., Ronveaux, C. C., & Raybould, H. E. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.06.003 · Cited by 120
Self-citationDonahey, J. C. K., van Dijk, G., Woods, S. C., & Seeley, R. J. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01057-3 · Cited by 119
A historical perspective on leptin
Coleman, D. L. (2010) · Nature Medicine · doi:10.1038/nm1010-1097 · Cited by 119
Leptin and CCK selectively activate vagal afferent neurons innervating the stomach and duodenum
Peters, J. H., Ritter, R. C., & Simasko, S. M. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00811.2005 · Cited by 114
Parker, J. A., McCullough, K. A., Field, B. C. T., Minnion, J. S., Martin, N. M., Ghatei, M. A., & Bloom, S. R. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.227 · Cited by 111
Seo, S., Ju, S., Chung, H., Lee, D., & Seungjoon, P. A. R. K. (2008) · Endocrine Journal · doi:10.1507/endocrj.k08e-091 · Cited by 109
Kakei, M., Yada, T., Nakagawa, A., & Nakabayashi, H. (2002) · Autonomic Neuroscience · doi:10.1016/s1566-0702(02)00182-0 · Cited by 109
Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter
Larsen, P. J., & Holst, J. J. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.08.026 · Cited by 108
The blood-brain barrier: connecting the gut and the brain
Banks, W. A. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2007.08.027 · Cited by 104
D’Alessio, D. A., Lu, W. J., Sun, W. Y., Zheng, S., Yang, Q., Seeley, R. J., Woods, S. C., & Tso, P. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00911.2006 · Cited by 104
Neary, N. M., Druce, M. R., Small, C. J., & Bloom, S. R. (2006) · PubMed Central · Cited by 102
Tang‐Christensen, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.2.711 · Cited by 100
Cholecystokinin Regulates Expression of Y2 Receptors in Vagal Afferent Neurons Serving the Stomach
Burdyga, G., de Lartigue, G., Raybould, H. E., Morris, R., Dimaline, R., Varró, A., Thompson, D. G., & Dockray, G. J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2493-08.2008 · Cited by 98
Self-citationExendin-4 Potently Decreases Ghrelin Levels in Fasting Rats
Pérez–Tilve, D., González-Matías, L. C., Álvarez-Crespo, M., Leiras, R., Tovar, S. A., Diéguez, C., & Mallo, F. (2006) · Diabetes · doi:10.2337/db05-0996 · Cited by 93
Chemosensory Perception in the Gut
Höfer, D., Asan, E., & Drenckhahn, D. (1999) · Physiology · doi:10.1152/physiologyonline.1999.14.1.18 · Cited by 93
Glucagon-like peptide 1 (GLP-1) suppresses ghrelin levels in humans via increased insulin secretion
Hagemann, D., Holst, J. J., Gethmann, A., Banasch, M., Schmidt, W. E., & Meier, J. J. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2007.03.002 · Cited by 84
de Lartigue, G., Lür, G., Dimaline, R., Varró, A., Raybould, H. E., & Dockray, G. J. (2010) · Endocrinology · doi:10.1210/en.2010-0106 · Cited by 83
Self-citationGlucagon-like peptide-1 binding to rat hepatic membranes
Villanueva‐Peñacarrillo, M. L., Delgado, E., Trapote, M. A., Alcántara, A., Clemente, F., Luque, M. A., Perea, A., & Valverde, I. (1995) · Journal of Endocrinology · doi:10.1677/joe.0.1460183 · Cited by 79
Zhao, S., Kanoski, S. E., Yan, J., Grill, H. J., & Hayes, M. R. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.265 · Cited by 79
Characterization of GLP-1 Effects on β-Cell Function After Meal Ingestion in Humans
Ahrén, B., Holst, J. J., & Mari, A. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2860 · Cited by 72
Flamez, D., Breusegem, A. V., Scrocchi, L. A., Quartier, E., PIPELEERS, D. G., Drucker, D. J., & Schuit, F. C. (1998) · Diabetes · doi:10.2337/diabetes.47.4.646 · Cited by 71
Glucagon-like peptide-1 binding to rat skeletal muscle
Delgado, E., Luque, M. A., Alcántara, A., Trapote, M. A., Clemente, F., Galera, C., Valverde, I., & Villanueva‐Peñacarrillo, M. L. (1995) · Peptides · doi:10.1016/0196-9781(94)00175-8 · Cited by 71
Rats with Hypothalamic Obesity Are Insensitive to Central Leptin Injections
Choi, S., Sparks, R., Clay, M. A., & Dallman, M. F. (1999) · Endocrinology · doi:10.1210/endo.140.10.7064 · Cited by 69
Dalvi, P. S., Nazarians-Armavil, A., Purser, M. J., & Belsham, D. D. (2012) · Endocrinology · doi:10.1210/en.2011-1795 · Cited by 69
Plasticity in vagal afferent neurones during feeding and fasting: mechanisms and significance*
Dockray, G. J., & Burdyga, G. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02219.x · Cited by 66
Baumgartner, I., Pacheco‐López, G., Rüttimann, E. B., Arnold, M., Asarian, L., Langhans, W., Geary, N., & Hillebrand, J. J. G. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.01995.x · Cited by 64
Punjabi, M., Arnold, M., Rüttimann, E., Graber, M., Geary, N., Pacheco-López, G., & Langhans, W. (2014) · Endocrinology · doi:10.1210/en.2013-1447 · Cited by 59
A Glucagon-Like Peptide-1 Receptor Agonist and an Antagonist Modify Macronutrient Selection by Rats
Peters, C. T., Choi, Y.-H., Brubaker, P. L., & Anderson, G. H. (2001) · Journal of Nutrition · doi:10.1093/jn/131.8.2164 · Cited by 51
Chelikani, P. K., Haver, A. C., & Reidelberger, R. D. (2006) · Diabetes · doi:10.2337/db06-0730 · Cited by 50
Barrachina, M. D., Martı́nez, V., Wei, J., & Taché, Y. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.272.3.r1007 · Cited by 49
Novel insight into the distribution of L-cells in the rat intestinal tract.
Hansen, C. F., Vrang, N., Sangild, P. T., & Jelsing, J. (2013) · Europe PMC (PubMed Central) · Cited by 45
Ability of GLP-1 to decrease food intake is dependent on nutritional status
Ronveaux, C. C., de Lartigue, G., & Raybould, H. E. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.06.015 · Cited by 44
Self-citationAsarian, L. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90655.2008 · Cited by 41
Bojanowska, E., & Nowak, A. (2007) · PubMed · Cited by 40
Boldbaatar, D., Dezaki, K., Kurashina, T., Sone, H., Rita, R. S., Kakei, M., & Yada, T. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.06.034 · Cited by 38
Alén, F., Crespo, I., Ramírez-López, M. T., Jagerovic, N., Goya, P., de Fonseca, F. R., de Heras, R. G., & Orío, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060918 · Cited by 36
Poleni, P.-E., Akieda‐Asai, S., Koda, S., Sakurai, M., Bae, C., Senba, K., Cha, Y., Furuya, M., & Date, Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.02.109 · Cited by 27
Hörsch, D., Göke, R., Eissele, R., Michel, B., & Göke, B. (1997) · Pancreas · doi:10.1097/00006676-199704000-00012 · Cited by 24
The Anorectic Effect of GLP-1 in Rats Is Nutrient Dependent
Sandoval, D. A., Barrera, J. G., Stefater, M. A., Sisley, S. R., Woods, S. C., D’Alessio, D. D., & Seeley, R. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051870 · Cited by 22
Bai, J. P. F. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90529-c · Cited by 21
Merchenthaler (1999) · doi:10.1002/(sici)1096-9861(19990111)403:2
Flagged first, then by citations
4 of the 122 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- ME, 2007, Mechanisms of Action of GLP-1 in the Pancreas, Pharmacotherapy, 113, 546
Cited by
Sorted by citations
Microbial regulation of organismal energy homeostasis
Cani, P. D., Van Hul, M., Lefort, C., Depommier, C., Rastelli, M., & Everard, A. (2019) · Nature Metabolism · doi:10.1038/s42255-018-0017-4 · Cited by 569
Zarrinpar, A., Chaix, A., Xu, Z. Z., Chang, M. W., Marotz, C. A., Saghatelian, A., Knight, R., & Panda, S. (2018) · Nature Communications · doi:10.1038/s41467-018-05336-9 · Cited by 546
Innate Immunity and Breast Milk
Cacho, N. T., & Lawrence, R. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00584 · Cited by 396
Knockdown of GLP-1 Receptors in Vagal Afferents Affects Normal Food Intake and Glycemia
Krieger, J.-P., Arnold, M., Pettersen, K. G., Lossel, P., Langhans, W., & Lee, S. J. (2016) · Diabetes · doi:10.2337/db15-0973 · Cited by 269
Hjerpsted, J. B., Flint, A., Brooks, A., Axelsen, M. B., Kvist, T., & Blundell, J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13120 · Cited by 245
Metadata
- Authors
- Ronveaux, C. C., Tomé, D., & Raybould, H. E.
- Affiliations
- AgroParisTech (FR)
- University of California, Davis (US)
- Corresponding author
- Raybould, Helen E
- Venue
- The Journal of Nutrition
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 145
- Issue
- 4
- Pages
- 672-680
- ISSN
- 0022-3166 (ISSN-L)
- PMC
- PMC4381768
- OpenAlex
- W2049375442
- Cited by
- 124
- References
- 122
- Citations by year
- 2026: 12 · 2025: 8 · 2024: 7 · 2023: 7 · 2022: 11 · 2021: 12 · 2020: 10 · 2019: 12 · 2018: 17 · 2017: 12 · 2016: 9 · 2015: 7
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Nutrition (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK041004)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- glucagon-like peptide-1, GLP-1 receptor, vagal afferent neurons, ghrelin, leptin, glucose metabolism, food intake regulation, satiation, glucose homeostasis, receptor translocation, gut-brain signaling
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Animals, Blood Glucose, Eating, Humans, Neurons, Afferent, Satiation, Signal Transduction, Receptors, Glucagon, Leptin, Gastrointestinal Tract, Glucagon-Like Peptide 1, Ghrelin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review